GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apogee Therapeutics, Inc. (APGE) | 8/10/2026 8:03:50 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $1,335,813,000 | EPS -$1.14 | ||
| Apogee Therapeutics, Inc. (APGE) | 8/10/2026 7:21:21 AM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $1,335,813,000 | EPS -$1.14 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 7/13/2026 5:17:06 PM | View | Proxy | SEC | Y 2025 | ||||||
| Apogee Therapeutics, Inc. (APGE) | 5/11/2026 7:35:54 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $1,293,654,000 | EPS -$1.06 | ||
| Apogee Therapeutics, Inc. (APGE) | 5/11/2026 7:11:22 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $1,293,654,000 | EPS -$1.06 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 4/24/2026 4:38:32 PM | View | Proxy | SEC | Y 2025 | ||||||
| Apogee Therapeutics, Inc. (APGE) | 3/2/2026 7:31:54 AM | Mid | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $937,134,000 | EPS -$4.22 | ||
| Apogee Therapeutics, Inc. (APGE) | 3/2/2026 7:15:52 AM | View | Financials | Earnings | SEC | Y 2025 | Assets $937,134,000 | EPS -$1.03 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 11/10/2025 7:42:17 AM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $626,159,000 | EPS -$1.11 | ||
| Apogee Therapeutics, Inc. (APGE) | 11/10/2025 7:21:41 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $626,159,000 | EPS -$1.11 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 8/11/2025 7:43:03 AM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $657,772,000 | EPS -$1.13 | ||
| Apogee Therapeutics, Inc. (APGE) | 8/11/2025 7:16:54 AM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $657,772,000 | EPS -$1.13 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 5/12/2025 6:41:45 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $714,162,000 | EPS -$0.95 | ||
| Apogee Therapeutics, Inc. (APGE) | 5/12/2025 6:16:22 AM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $714,162,000 | EPS -$0.95 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 4/29/2025 4:48:26 PM | View | Proxy | SEC | Y 2024 | ||||||
| Apogee Therapeutics, Inc. (APGE) | 3/3/2025 7:14:10 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $753,951,000 | EPS -$1.19 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 3/3/2025 6:45:52 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $753,951,000 | EPS -$3.30 | ||
| Apogee Therapeutics, Inc. (APGE) | 11/12/2024 9:33:23 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $776,286,000 | EPS -$0.86 | ||
| Apogee Therapeutics, Inc. (APGE) | 11/12/2024 9:23:20 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $776,286,000 | EPS -$0.86 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 8/12/2024 7:19:32 AM | Mid | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $800,657,000 | EPS -$0.60 | ||
| Apogee Therapeutics, Inc. (APGE) | 8/12/2024 6:36:19 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $800,657,000 | EPS -$0.60 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 5/13/2024 7:27:29 AM | Mid | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $823,659,000 | EPS -$0.64 | ||
| Apogee Therapeutics, Inc. (APGE) | 5/13/2024 7:06:30 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $823,659,000 | EPS -$0.64 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 4/24/2024 4:24:53 PM | View | Proxy | SEC | Y 2023 | ||||||
| Apogee Therapeutics, Inc. (APGE) | 3/5/2024 6:29:31 AM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $401,404,000 | EPS -$3.36 | ||
| Apogee Therapeutics, Inc. (APGE) | 3/5/2024 6:12:16 AM | View | Financials | Earnings | SEC | Y 2023 | Assets $401,404,000 | EPS -$0.32 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 11/13/2023 7:55:04 AM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $426,421,000 | EPS -$0.51 | ||
| Apogee Therapeutics, Inc. (APGE) | 11/13/2023 7:44:24 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $426,421,000 | EPS -$0.51 | Export Earnings Model | ||
| Apogee Therapeutics, Inc. (APGE) | 8/28/2023 8:16:22 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $130,667,000 | EPS -$3.78 | ||
| Apogee Therapeutics, Inc. (APGE) | 8/28/2023 7:36:12 AM | View | Earnings | SEC | 2Q 2023 | Assets $130,667,000 | EPS -$3.78 |